Description
PD-1 (Pembrolizumab Biosimilar) Human mAb was confirmed to bind to its intended target protein PD-1 using flow cytometry. PD-1 (Pembrolizumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Pembrolizumab is an antibody that is directed against the extracellular region of human PD-1.
Target
PDCD1
Target Alias Names
PDCD1, PD-1
Isotype/Mimetic
IgG4 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation